Format
Sort by

Send to

Choose Destination

Links from Nucleotide

Items: 6

1.

Genetic Evidence for O-Specific Antigen as Receptor of Pseudomonas aeruginosa Phage K8 and Its Genomic Analysis.

Pan X, Cui X, Zhang F, He Y, Li L, Yang H.

Front Microbiol. 2016 Mar 2;7:252. doi: 10.3389/fmicb.2016.00252. eCollection 2016.

2.

Predicting in vivo efficacy of therapeutic bacteriophages used to treat pulmonary infections.

Henry M, Lavigne R, Debarbieux L.

Antimicrob Agents Chemother. 2013 Dec;57(12):5961-8. doi: 10.1128/AAC.01596-13. Epub 2013 Sep 16.

3.

Genomic and proteomic analyses of the terminally redundant genome of the Pseudomonas aeruginosa phage PaP1: establishment of genus PaP1-like phages.

Lu S, Le S, Tan Y, Zhu J, Li M, Rao X, Zou L, Li S, Wang J, Jin X, Huang G, Zhang L, Zhao X, Hu F.

PLoS One. 2013 May 13;8(5):e62933. doi: 10.1371/journal.pone.0062933. Print 2013.

4.

Sequencing and characterization of Pseudomonas aeruginosa phage JG004.

Garbe J, Bunk B, Rohde M, Schobert M.

BMC Microbiol. 2011 May 14;11:102. doi: 10.1186/1471-2180-11-102.

5.

Bacteriophages can treat and prevent Pseudomonas aeruginosa lung infections.

Debarbieux L, Leduc D, Maura D, Morello E, Criscuolo A, Grossi O, Balloy V, Touqui L.

J Infect Dis. 2010 Apr 1;201(7):1096-104. doi: 10.1086/651135.

6.

Blood kinetics of four intraperitoneally administered therapeutic candidate bacteriophages in healthy and neutropenic mice.

Uchiyama J, Maeda Y, Takemura I, Chess-Williams R, Wakiguchi H, Matsuzaki S.

Microbiol Immunol. 2009 May;53(5):301-4. doi: 10.1111/j.1348-0421.2009.00125.x. Epub 2009 Feb 18.

Items per page

Supplemental Content

Write to the Help Desk